Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Antibiotics (Basel, Switzerland)
|
June 25, 2025
Development of a System to Deliver Inhalational Antibiotics to Marmosets
Rachel E Ireland, Stuart J Armstrong, Carwyn Davies, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2025
Inhaled liposomal ciprofloxacin protects against lethal tularemia in the common marmoset
Rachel E Ireland, Alejandro Nunez, Wendy Butcher, et al.
The Lancet. Respiratory Medicine
|
January 20, 2019
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Charles S Haworth, Diana Bilton, James D Chalmers, et al.
Thorax
|
May 18, 2013
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
David J Serisier, Diana Bilton, Anthony De Soyza, et al.
Pharmaceutical Research
|
November 24, 2004
Effect of gender and device mouthpiece shape on bolus insulin aerosol delivery using the AERx pulmonary delivery system
Brooks Boyd, Peter Noymer, Kui Liu, et al.
Journal of Clinical Pharmacology
|
January 14, 2005
Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women
Sonia Davison, John Thipphawong, Jim Blanchard, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
December 8, 2010
Deposition, imaging, and clearance: what remains to be done?
Gerhard Scheuch, William Bennett, Lars Borgström, et al.
Pharmaceutics
|
August 28, 2021
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
Waiting Tai, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, et al.
Pharmacological Reviews
|
January 6, 2022
Inhaled Medicines: Past, Present, and Future
Sandra Anderson, Paul Atkins, Per Bäckman, et al.
Pharmaceutical Research
|
August 16, 2002
Evaluation of the AERx pulmonary delivery system for systemic delivery of a poorly soluble selective D-1 agonist, ABT-431
Franklin W Okumu, Rai-Yun Lee, James D Blanchard, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Antibiotics (Basel, Switzerland)
|
June 25, 2025
Development of a System to Deliver Inhalational Antibiotics to Marmosets
Rachel E Ireland, Stuart J Armstrong, Carwyn Davies, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2025
Inhaled liposomal ciprofloxacin protects against lethal tularemia in the common marmoset
Rachel E Ireland, Alejandro Nunez, Wendy Butcher, et al.
The Lancet. Respiratory Medicine
|
January 20, 2019
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Charles S Haworth, Diana Bilton, James D Chalmers, et al.
Thorax
|
May 18, 2013
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
David J Serisier, Diana Bilton, Anthony De Soyza, et al.
Pharmaceutical Research
|
November 24, 2004
Effect of gender and device mouthpiece shape on bolus insulin aerosol delivery using the AERx pulmonary delivery system
Brooks Boyd, Peter Noymer, Kui Liu, et al.
Journal of Clinical Pharmacology
|
January 14, 2005
Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women
Sonia Davison, John Thipphawong, Jim Blanchard, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
December 8, 2010
Deposition, imaging, and clearance: what remains to be done?
Gerhard Scheuch, William Bennett, Lars Borgström, et al.
Pharmaceutics
|
August 28, 2021
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
Waiting Tai, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, et al.
Pharmacological Reviews
|
January 6, 2022
Inhaled Medicines: Past, Present, and Future
Sandra Anderson, Paul Atkins, Per Bäckman, et al.
Pharmaceutical Research
|
August 16, 2002
Evaluation of the AERx pulmonary delivery system for systemic delivery of a poorly soluble selective D-1 agonist, ABT-431
Franklin W Okumu, Rai-Yun Lee, James D Blanchard, et al.
Page
of 4